These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15784158)

  • 1. Neuropeptide Y and corticotropin-releasing hormone in CSF mark response to antidepressive treatment with citalopram.
    Nikisch G; Agren H; Eap CB; Czernik A; Baumann P; Mathé AA
    Int J Neuropsychopharmacol; 2005 Sep; 8(3):403-10. PubMed ID: 15784158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quetiapine affects neuropeptide Y and corticotropin-releasing hormone in cerebrospinal fluid from schizophrenia patients: relationship to depression and anxiety symptoms and to treatment response.
    Nikisch G; Baumann P; Liu T; Mathé AA
    Int J Neuropsychopharmacol; 2012 Sep; 15(8):1051-61. PubMed ID: 22008251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF monoamine metabolites and neuropeptides in depressed patients before and after electroconvulsive therapy.
    Nikisch G; Mathé AA
    Eur Psychiatry; 2008 Aug; 23(5):356-9. PubMed ID: 18455913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early life stress changes concentrations of neuropeptide Y and corticotropin-releasing hormone in adult rat brain. Lithium treatment modifies these changes.
    Husum H; Mathé AA
    Neuropsychopharmacology; 2002 Nov; 27(5):756-64. PubMed ID: 12431850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic parenteral antidepressant treatment in rats: unaltered levels and processing of neuropeptide Y (NPY) and corticotropin-releasing hormone (CRH).
    Heilig M; Ekman R
    Neurochem Int; 1995 Apr; 26(4):351-5. PubMed ID: 7633328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment.
    Heuser I; Bissette G; Dettling M; Schweiger U; Gotthardt U; Schmider J; Lammers CH; Nemeroff CB; Holsboer F
    Depress Anxiety; 1998; 8(2):71-9. PubMed ID: 9784981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topiramate normalizes hippocampal NPY-LI in flinders sensitive line 'depressed' rats and upregulates NPY, galanin, and CRH-LI in the hypothalamus: implications for mood-stabilizing and weight loss-inducing effects.
    Husum H; Van Kammen D; Termeer E; Bolwig G; Mathé A
    Neuropsychopharmacology; 2003 Jul; 28(7):1292-9. PubMed ID: 12700690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid and plasma concentrations of SRIH, beta-endorphin, CRH, NPY and GHRH in obese and normal weight subjects.
    Brunani A; Invitti C; Dubini A; Piccoletti R; Bendinelli P; Maroni P; Pezzoli G; Ramella G; Calogero A; Cavagnini F
    Int J Obes Relat Metab Disord; 1995 Jan; 19(1):17-21. PubMed ID: 7719386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shunt related changes in somatostatin, neuropeptide Y, and corticotropin releasing factor concentrations in patients with normal pressure hydrocephalus.
    Poca MA; Mataró M; Sahuquillo J; Catalán R; Ibañez J; Galard R
    J Neurol Neurosurg Psychiatry; 2001 Mar; 70(3):298-304. PubMed ID: 11181849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptides and electroconvulsive treatment.
    Mathé AA
    J ECT; 1999 Mar; 15(1):60-75. PubMed ID: 10189619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptides in relation to suicidal behavior in depression.
    Roy A
    Neuropsychobiology; 1993; 28(4):184-6. PubMed ID: 7903797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal neuropeptide Y and substance P in suicide attempters during long-term antidepressant treatment.
    Olsson A; Regnéll G; Träskman-Bendz L; Ekman R; Westrin A
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):479-85. PubMed ID: 15589387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid concentrations of neuropeptide Y in depressed patients and in controls.
    Gjerris A; Widerlöv E; Werdelin L; Ekman R
    J Psychiatry Neurosci; 1992 Mar; 17(1):23-7. PubMed ID: 1349825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low neuropeptide Y in cerebrospinal fluid in bipolar patients is associated with previous and prospective suicide attempts.
    Sandberg JV; Jakobsson J; Pålsson E; Landén M; Mathé AA
    Eur Neuropsychopharmacol; 2014 Dec; 24(12):1907-15. PubMed ID: 25453484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proinflammatory and "resiliency" proteins in the CSF of patients with major depression.
    Martinez JM; Garakani A; Yehuda R; Gorman JM
    Depress Anxiety; 2012 Jan; 29(1):32-8. PubMed ID: 21898706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression.
    De Bellis MD; Gold PW; Geracioti TD; Listwak SJ; Kling MA
    Am J Psychiatry; 1993 Apr; 150(4):656-7. PubMed ID: 8465888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and diazepam-binding inhibitor (DBI) during alcohol withdrawal and abstinence.
    Adinoff B; Anton R; Linnoila M; Guidotti A; Nemeroff CB; Bissette G
    Neuropsychopharmacology; 1996 Sep; 15(3):288-95. PubMed ID: 8873112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid neuropeptide Y-like immunoreactivity correlates with impulsive aggression in human subjects.
    Coccaro EF; Lee R; Liu T; Mathé AA
    Biol Psychiatry; 2012 Dec; 72(12):997-1003. PubMed ID: 22985695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF neuropeptide Y in alcoholics and normal controls.
    Roy A; Berrettini W; DeJong J; Adinoff B; Ravitz B; Linnoila M
    Psychiatry Res; 1990 Sep; 33(3):215-9. PubMed ID: 1978753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans.
    Geracioti TD; Orth DN; Ekhator NN; Blumenkopf B; Loosen PT
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1325-30. PubMed ID: 1317385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.